In June 2018, the FDA gave its blessing to Epidiolex, and soon after, Congress passed the Farm Bill, which removed cannabis containing less than 0.3% THC from the definition of marijuana. So, CBD is legal…right? Well kind of.
2021 has the potential to be remembered as the year when minor cannabinoids achieved major status. While it’s true that the cannabis market is generally interested in THC and CBD, cannabinoids such as THCV and CBN have started to attract attention on their own.
In the previous post we discussed the first line of questions to ask your CBD ingredient supplier. Once you have those adequately answered, you are ready to graduate to the next level of qualification.
There is a lot of confusion about how to evaluate the ‘best’ CBD ingredients that will be consumed as finished products. But the types of questions to qualify a CBD ingredient for your consumer product starts out as basic, simple questions.
During this unprecedented time, most people have been rightfully concerned with this invisible viral enemy called COVID-19. The role the endocannabinoid system (ECS) plays in strengthening the immune system must not be ignored.